Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
4th Aug 200611:01 amRNSMerger Update
2nd Aug 200610:52 amRNSAdjournment of EGM
1st Aug 20065:20 pmRNSAdjournment of EGM
26th Jul 20065:39 pmRNSResponse to Possible Offer
14th Jul 20067:00 amRNSRule 8.4 Disclosure
12th Jul 200611:11 amRNSDisclosure Rule 8.4
10th Jul 20061:32 pmRNSMerger Update
10th Jul 20061:06 pmRNSRule 8.3-Wilmington Group Plc
7th Jul 20064:41 pmRNSDisclosure under Rule 8.4
29th Jun 20061:16 pmRNSRule 8.4 Disclosure
26th Jun 20067:00 amRNSMerger
15th May 20067:01 amRNSAcquisition
16th Mar 20067:03 amRNSInterim Results
15th Feb 200610:33 amRNSNotice of Results
9th Feb 20067:00 amRNSAcquisition
13th Jan 20066:01 pmRNSHolding(s) in Company
9th Jan 20066:15 pmRNSHolding(s) in Company
8th Dec 20057:00 amRNSTrading Statement
21st Nov 20055:17 pmRNSHolding(s) in Company
21st Nov 20055:17 pmRNSHolding(s) in Company
16th Nov 20053:01 pmRNSDirector/PDMR Shareholding
11th Nov 20053:39 pmRNSHolding(s) in Company
9th Nov 20053:32 pmRNSAGM Statement
9th Nov 20057:01 amRNSIFRS Statement
27th Oct 20055:10 pmRNSDirector/PDMR Shareholding
20th Oct 20057:04 amRNSAcquisition
19th Oct 20059:22 amRNSAnnual Information Update
6th Oct 200512:12 pmRNSAnnual Report and Accounts
29th Sep 200511:28 amRNSHolding(s) in Company
22nd Sep 20059:22 amRNSDirector/PDMR Shareholding
15th Sep 20057:03 amRNSFinal Results
13th Sep 20051:25 pmRNSDisposal
26th Aug 200511:52 amRNSNotice of Results
14th Jul 20057:00 amRNSPre-Close Period Statement
16th Jun 20057:00 amRNSBoard Changes
19th May 20057:00 amRNSAcquisition
7th Apr 20057:00 amRNSDirectorate Change
24th Feb 20057:01 amRNSInterim Results
22nd Feb 20053:38 pmRNSAdditional Listing
25th Jan 20057:00 amRNSNotice of Results
19th Jan 20057:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.